Rallybio
Price & Volume
Stats
See more52W Range | $2.16-$11.49 |
Market Cap | $46.9M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $858,000 |
Revenue Growth (YoY) | 484.2% |
Gross Profit (12 Mos) | -$17.5M |
Diluted EPS | -$1.59 |
News
See moreYahoo Finance • last month
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Rallybio Corporation (Nasdaq – RLYB), SunOpta Inc. (Nasdaq – STKL), Talkspace, Inc. (Nasdaq - TALK), Kennedy-Wilson Holdings, Inc. (Nasdaq - KW)
Yahoo Finance • last month
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—ALIS, TALK, JTAI, and RLYB
Yahoo Finance • 2 months ago
Rallybio to acquire Candid Therapeutics
Yahoo Finance • 6 months ago
After-Hours Biotech Watch: IFRX, ABCL, RLYB Among Notable Risers
About
CEO | Dr. Stephen Uden M.D., MBBS |
CFO | Mr. Jonathan I. Lieber M.B.A. |
Address | 234 Church Street, New Haven, CT, United States, 06510 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 14 |